"It is based on exosomes that the body is releasing from the cell membrane and uses for intercellular communication. We enrich the exosomes with the 24CD protein, which is known to play an important role in regulating the immune system," according to Arber's director of laboratory Dr. Shiran Shapira, who has been conducting research on CD24 protein for decades.
The medicine will now move on to additional trial phases, though the hospital sees it as a potential game-changer.
wow love it. Whoaaaa!!!!!!
Value in new medicines and longer strides, page-60
Add TYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.002(8.11%) |
Mkt cap ! $21.78M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.0¢ | 1.9¢ | $57.60K | 2.928M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1076509 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 277183 | 2 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| TYP (ASX) Chart |